|1.||Campa, Ana: 2 articles (04/2014 - 07/2013)|
|2.||Tufik, Sérgio: 1 article (04/2014)|
|3.||Gomes, Melissa M: 1 article (04/2014)|
|4.||Catalani, Luiz H: 1 article (04/2014)|
|5.||Coimbra, Janine B: 1 article (04/2014)|
|6.||Chagas, Jair R: 1 article (04/2014)|
|7.||Dörr, Felipe A: 1 article (04/2014)|
|8.||Moreno, Ana Carolina R: 1 article (04/2014)|
|9.||Clara, Renan O: 1 article (04/2014)|
|10.||Pinto, Ernani: 1 article (04/2014)|
|1.||Schizophrenia (Dementia Praecox)
12/01/1973 - "The dimethyltryptamine-forming enzyme in blood platelets: a study in monozygotic twins discordant for schizophrenia."
01/01/1974 - "N,N-dimethyltryptamine--a possible relationship to schizophrenia?"
06/01/1979 - "Dimethyltryptamine excretion was greatest in schizophrenia, mania, and "other psychosis" and tended to decline as clinical state improved. "
01/01/1978 - "Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia."
09/01/1993 - "Furthermore, the psychotomimetic effects of drugs affecting serotoninergic neurotransmission such as LSD, psilocybin, N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine also contributed to draw attention onto a possible involvement of serotoninergic systems in at least some of the disorders typical of schizophrenia. "
|2.||Bipolar Disorder (Mania)
|3.||Psychotic Disorders (Schizoaffective Disorder)
08/01/1974 - "Blood dimethyltryptamine concentrations in psychotic disorders."
02/02/1974 - "Letter: Blood and urinary dimethyltryptamine in acute psychotic disorders."
01/01/1970 - "[N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses]."
02/01/2006 - "The NMDA antagonist state (PCP, ketamine) resembles undifferentiated psychoses with positive and negative symptoms, while the 5-HT(2A) agonist state (LSD, dimethyltryptamine (DMT)) is thought to be an appropriate model for psychoses with prominent positive symptoms. "
05/01/1980 - "1 N,N-Dimethyltryptamine (DMT) in pargyline pretreated rodents induced a dose-dependent behavioural syndrome consisting of hyperactivity, prostration and hindlimb abduction, mild tremor, Straub tail, retropulsion and jerking. "
01/01/1991 - "Idazoxan pre-treatment, in rats, enhanced forepaw treading, head weaving and tremor induced by the 5-HT agonist 5-methoxy-N,N dimethyltryptamine (5-MeODMT), increased head twitches (but decreased hindlimb abduction) induced by the 5-HT releaser p- chloroamphetamine (pCA), but did not clearly alter head twitches induced by the 5-HT precursor L-5-hydroxytryptophan in mice. "
09/01/1970 - "Effects of psilocybin, dimethyltryptamine and various lysergic acid derivatives on photically-induced epilepsy in the baboon (Papio papio)."
12/01/1971 - "Effects of psilocybin, dimethyltryptamine, mescaline and various lysergic acid derivatives on the EEG and on photically induced epilepsy in the baboon (Papio papio)."
|1.||Serotonin (5 Hydroxytryptamine)
|3.||Monoamine Oxidase (MAO)
|4.||5-Methoxytryptamine (5 Methoxytryptamine)
|5.||Lysergic Acid Diethylamide (LSD)